Pathology Analysis & Statistics, February 2015 (p5)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

121-150 of about 4 800 reports

Purchase Reports From Reputable Market Research Publishers

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Pathology
  • Countries : United States
Acute Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about ...

  • Industries : Pathology
  • Countries : United States
Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Pathology
  • Countries : United States
Ankylosing Spondylitis (Bekhterev's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Ankylosing Spondylitis (Bekhterev's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Ankylosing Spondylitis (Bekhterev's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline ...

  • Industries : Pathology
  • Countries : United States
Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Athlete's Foot (Tinea Pedis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Athlete's Foot (Tinea Pedis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Athlete's Foot (Tinea Pedis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Pathology
  • Countries : United States
Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Atrial Fibrillation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Atrial Fibrillation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Atrial Fibrillation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Atrial Flutter-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Atrial Flutter-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Atrial Flutter-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Attention Deficit Hyperactivity Disorder (ADHD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Attention Deficit Hyperactivity Disorder (ADHD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Attention Deficit Hyperactivity Disorder (ADHD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline ...

  • Industries : Pathology
  • Countries : United States
Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Benign Prostatic Hyperplasia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Benign Prostatic Hyperplasia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Benign Prostatic Hyperplasia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Pathology
  • Countries : United States
Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Pathology
  • Countries : United States
Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Chronic Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chronic Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Chronic Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Pathology
  • Countries : United States
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase ...

  • Industries : Pathology
  • Countries : United States
Chronic Obstructive Pulmonary Disease (COPD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chronic Obstructive Pulmonary Disease (COPD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Chronic Obstructive Pulmonary Disease (COPD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline ...

  • Industries : Pathology
  • Countries : United States
Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Pathology
  • Countries : United States
Duodenal Ulcer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Duodenal Ulcer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Duodenal Ulcer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Pathology
  • Countries : United States
Herpes Labialis (Oral Herpes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Herpes Labialis (Oral Herpes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Herpes Labialis (Oral Herpes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Pathology
  • Countries : United States
Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Pathology
  • Countries : United States
Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Pathology
  • Countries : United States
About 34 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • March 2015
    9 pages
  • Pathology  

    Tuberculosis  

  • United States  

View report >

About 200 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.